Company Profiles

driven by the PitchBook Platform

Veran Medical Technologies

Veran Medical Technologies
2005 FOUNDED
PRIVATE STATUS
51-200 EMPLOYEES
Later Stage VC LATEST DEAL TYPE
$31M LATEST DEAL AMOUNT
$121M TOTAL AMOUNT RAISED
Description

Developer of percutaneous technology for diagnosis of lung cancer and therapy delivery. The company develops medical devices for invasive delivery of interventional oncology therapies. It also provides plug-n-play delivery systems and navigated instruments.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Therapeutic Devices
Drug Delivery
Primary Office
1908 Innerbelt Business Center Drive
Overland, MO 63114
United States

+1 (314) 659-8500
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Veran Medical Technologies’s full profile, request a free trial.

Veran Medical Technologies Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Later Stage VC 21-Dec-2016 $31M $121M Completed Generating Revenue
8. Later Stage VC (Series D) 29-Sep-2015 000.00 000.00 Completed Generating Revenue
7. Later Stage VC 29-Oct-2014 0000 000.00 000.00 Completed Generating Revenue
6. Secondary Transaction - Private 000.00 Completed Generating Revenue
5. Later Stage VC (Series C) 20-Sep-2011 000.00 000.00 000.00 Completed Generating Revenue
4. Later Stage VC 29-Mar-2011 00.00 000.00 Completed Generating Revenue
3. Early Stage VC (Series B) 12-May-2008 00.000 00.000 0000 Completed Startup
2. Early Stage VC (Series A) 18-Jan-2008 $1.15M $2.48M Completed Startup
1. Early Stage VC 14-Jan-2005 $1.33M $1.33M Completed Startup
To view this company’s complete deal history including valuation and funding request access »

Veran Medical Technologies Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series C1 00,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series C 00,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series B 13,321,930 $0.001000 6% $0.39 $0.58 1x $0.39 13.13%
Series A 5,225,201 $0.001000 6% $0.35 $0.53 1x $0.35 5.15%
To view this company’s complete Cap Table request access »

Veran Medical Technologies Investors (13)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
3G Capital PE/Buyout Minority 000 0000 000000 0
Advantage Capital (St. Louis) Venture Capital Minority 000 0000 000000 0
American Milling Other Minority 000 0000 000000 0
Dynamic Investments Other Minority 000 0000 000000 0
GE Ventures Corporate Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 13 investors. Get the full list »

Veran Medical Technologies Executive Team (11)

Name Title Board
Seat
Contact
Info
Jason Pesterfield President, Chief Executive Officer & Board Member
Kirk Jacquay Chief Financial Officer & Corporate Secretary
Troy Holsing Chief Technical Officer & Vice President Application Development
Jerry Hu Director, Asia Pacific Business Development
Maureen Oehler Director, Finance and Accounting
You’re viewing 5 of 11 executives. Get the full list »

Veran Medical Technologies Board Members (12)

Name Representing Role Since Contact
Info
Ajit Shah Ph.D Self Board Member 000 0000
Curt Hartman Self Board Member 000 0000
David Adair MD Self Board Member 000 0000
David Kereiakes River Cities Capital Funds Board Member 000 0000
Gregory Johnson Ph.D Prolog Ventures Chairman 000 0000
You’re viewing 5 of 12 board members. Get the full list »